However, diabetes mellitus make it more complicated for the selection of the therapeutic treatments given the sustained hyperglycemia, hyperinsulinemia, insulin resistance (IR), and insulin-like growth factor-1 (IGF-1) play a role in cancer progression and promotion. This evidence concerns the gene IGF1 and Hyperglycemia.